Likewise, the systemic administration of either SaCas9 or SpCas9 with two sgRNAs targeting introns 51 and 53 produces widespread dystrophin restoration in the cardiac, diaphragmatic and skeletal muscles of DMD mdx4Cv mice harboring a point mutation in exon 53 [128,129]. The gene discussed is DMD; the disease is Duchenne muscular dystrophy.